Pharmacovigilance news
58th AFI Symposium: innovation in pharmaceutical sector
The AFI Symposium took place in Rimini at the convention center on 6-7-8 June. The topic of this 58th edition was the technological innovations in the medical field.
5 things to remember from the European PharmacoVigilance Day 2017
The first edition of the European PharmacoVigilance Day took place on 30th November 2017 in Milan. The topics of the speakers were: the procedural changes, the news of EudraVigilance and the importance of signal detection.
EU PhV Day: the Business Intelligence and ICH R3 rules
During the European PharmacoVigilance Day on 30th November 2017, Mr Garlanda of Max Application introduced the analyses with SafetyDrugs 6.
EU PhV Day: be compliant with worldwide pharmacovigilance standards
The European PharmacoVigilance Day took place in Milan, the event where Mr Ghiglione revealed some news about SafetyDrugs 6.
3 questions about SafetyDrugs 6 from our clients
We presented SafetyDrugs 6, the new native ICH R3 version of our pharmacovigilance database, to our customers. Here are the questions that arose.
10 points of reflection that came up during the 57th AFI Symposium
From 7th to 9th June 2017 took place the 57th edition af AFI Symposium. Here are ten aspects raised during the seminars.
Pharmacovigilance defines new standards
SafetyDrugs, the pharmacovigilance software made in Italy, is preparing itself for the new parameters. Here are some of the news that await you!
3D printing: which prospects in medical field?
What developments are there in the use of 3d printing in the medical field? It was discussed at CPhI 2016. Here is what emerged.
Biosimilars: a market growing 20-fold by 2020
Biosimilars is a market that has grown considerably in recent years. We talked about it at CPhI 2016 in Barcelona, which we participated in from 4 to 6 October.
Why to pay for somenthing that you don’t use? Choose SaaS!
Pharmacovigilance becomes accessible to everybody with Saas! Enjoy the on-cloud service, set it up and pay just for your real demands.
EMA postpones the ICH R3 rules entry into force
EMA postpones the entry into force of the ICH R3 regulations: this is what emerged at the round table organized by Asgenia where, to the users of SafetyDrugs, Max Application explained the migration to ICH R3.
“With SafetyDrugs 6.0 you choose when to switch to new ICH R3”
The project manager Carlo Ghiglione replies to some questions about the switch to the new rules ICH R3. Here is what is important to know.